Chichi Huang, Ph.D.

VP, Head of Biologics

Dr. ChiChi Huang joined BeiGene in September 2019 and is the Vice President, Head of Biologics. Prior to joining BeiGene, Dr. Huang has over twenty years of extensive scientific and management experience at Pfizer and Johnson & Johnson, with broad expertise in diverse therapeutic modalities, including monoclonal antibodies, peptides, fusion proteins, and vaccines.

Dr. Huang obtained his doctoral degree in Biochemistry from Tufts University Graduate School of Biomedical Sciences and completed his post-doctoral training at Harvard University Medical School.

You are now leaving BeiGene Australia


BeiGene provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained byBeiGene Australia, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.

You will be redirected to

Click the link above to continue or CANCEL